EDGAR Filing Documents for 0001193125-15-098537

Form 8-K - Current report:

SEC Accession No. 0001193125-15-098537

Filing Date

2015-03-19

Accepted

2015-03-19 16:11:33

Documents

Period of Report

2015-03-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d893287d8k.htm	8-K	18150
2	EX-1.1	d893287dex11.htm	EX-1.1	191839
3	EX-5.1	d893287dex51.htm	EX-5.1	8829
4	EX-99.1	d893287dex991.htm	EX-99.1	8290
5	GRAPHIC	g893287ex5_1pg001a.jpg	GRAPHIC	3824
6	GRAPHIC	g893287ex5_1pg001b.jpg	GRAPHIC	18171
7	GRAPHIC	g893287ex991_pg001.jpg	GRAPHIC	15053
	Complete submission text file	0001193125-15-098537.txt		279865

Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421

Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045

CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 15713025
SIC: 2834 Pharmaceutical Preparations